aims

“Expanding AI Technology in Human Oncology: The Mission of ImpriMed, a Revolutionary Dog Cancer Treatment”

Gettyimages 1397710182
ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers. The startup, which centers on improving treatment outcomes of dogs and cats with cancer first, now aims to expand its precision medicine technology for human oncology applications. “Also, the proven know-how acquired from developing AI algorithms in veterinary oncology streamlines the building of new predictive models in human oncology. For human precision oncology, its AI software for multiple myeloma, a rare blood cancer, is in the process of approval, aiming to commercialize in 2025, Lim told TechCrunch. ImpriMed’s unique strength is “the ability to develop and incorporate AI models into the personalized medicine service workflow,” according to Lim.

Meta plans to offer its fact-checking program in Threads next year

Threads Gettyimages 1524134312
With two large-scale elections in the U.S. in India next year, Threads aims to introduce a fact-checking checking program to the social network. Instagram head Adam Mosseri said that the social platform currently matches ratings from Facebook or Instagram to similar content. Separately, Meta shared in a blog post that soon U.S-based Threads users will be able to increase, decrease, or maintain the same level of demotion on fact-checked posts. Meta and Threads haven’t been keen on bolstering news on the platform. And while Threads has stayed away from news until now, with fact-checking programs it will have to get involved.